Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 12:26 AM
NCT ID:
NCT00181558
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed adenocarcinoma of the prostate
* History of bilateral orchiectomy or current treatment with a GnRH agonist or antagonist
* Radiographically documented bone metastases
* Disease progression according to criteria from the PSA Working Group
Exclusion Criteria:
* Prior treatment with Atrasentan or Zometa within one year
* Serum creatinine \> 2.0mg/dL
* Documented cardiovascular disability status of New York Heart Association Class 2
* Treatment with chemotherapy, radiation, steroids, estrogens, or PC-SPES within 6 weeks
* Treatment with bisphosphonates or radiopharmaceuticals within 12 weeks
* History of Paget's disease, hyperthyroidism, hyperparathyroidism, Cushing's syndrome, hyperprolactinemia or other disorder associated with metabolic bone disease.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT00181558
Study Brief:
Protocol Section:
NCT00181558